Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the parma trial

Journal of Clinical Oncology

Volumn 16, Issue 10, 1998, Pages 3264-3269

  Guglielmi, Cesare ^a   Gomez, Frederic ^a   Philip, Thierry ^a   Hagenbeek, Anton ^a   Martelli, Maurizio ^a   Sebban, Catherine ^a   Milpied, Noel ^a   Bron, Dominique ^a   Cahn, Jean Yves ^a   Somers, Renier ^a   Sonneveld, Pieter ^a   Gisselbrecht, Christian ^a   Van Der Lelie, Hans ^a   Chauvin, Frank ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SURVIVAL RATE; TUMOR VOLUME;

EID: 0031757275     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.10.3264     Document Type: Article

References (25)

1. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
2. Takvorian T, Canellos GP, Ritz J, et al: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316:1499-1505, 1987
3. Philip T, Hartmann O, Biron P, et al: High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol 6:1118-1124, 1988
4. Gulati S, Yahalom J, Acaba L, et al: Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous bone marrow transplantation. J Clin Oncol 10:936-941, 1992
5. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
6. Gianni AM, Bregni M, Siena S, et al: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290-1297, 1997
7. Verdonck LF, van Putten WLJ, Hagenbeek A, et al: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1045-1051, 1995
8. Martelli M, Vignetti M, Zinzani PL, et al: High-dose chemotherapy followed by autologous bone marrow transplantation versus dexametha-sone, cisplatin and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective random-ized Italian multicenter study. J Clin Oncol 14:534-542, 1996
9. Haioun C, Lepage E, Gisselbrecht C, et al: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543-2551, 1995
10. Appelbaum FR, Herzig GP, Ziegler JL, et al: Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52:85-95, 1978
11. Bosly A, Coiffier B, Gisselbrecht C, et al: Bone marrow transplantation prolongs survival after relapse in aggressive lymphoma patients treated with the LNH84 regimen. J Clin Oncol 10:1615-1623, 1992
12. Gisselbrecht C, Bosly A, Lepage E, et al: Autologous hematopoietic stem cell transplantation in intermediate- and high-grade non-Hodgkin's lymphoma: A review. Ann Oncol 4:7-13, 1993 (suppl 1)
13. Vose JM, Anderson JR, Kessinger A, et al: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846-1851, 1993
14. Freedman AS, Nadler LM: Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? J Clin Oncol 11:1841-1843, 1993
15. Haioun C, Lepage E, Gisselbrecht C, et al: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH 87-2. J Clin Oncol 15:1131-1137, 1997
16. Dupriez B, Morel P, Fenaux P, et al: VIM3-Ara C: An effective salvage regimen in refractory or recurrent aggressive non-Hodgkin's lymphoma. A report on 18 cases. Hematol Oncol 9:259-268, 1991
17. Armitage JO: Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023-1030, 1993
18. Velasquez WS, Cabanillas F, Salvador P, et al: Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71:117-122, 1988
19. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
20. Blay J-Y, Gomez F, Bachelot T, et al: The International Prognostic Index correlates to survival in intermediate-high grade lymphoma (NHL) in relapse: Analysis of the PARMA trial. Proc Am Soc Clin Oncol 15:151, 1996(abstr)
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
22. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-180, 1966
23. Cox DR: Regression models and life tables. J Royal Stat Soc 34:187-220, 1972
24. Petersen FB, Appelbaum FR, Hill R, et al: Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle. J Clin Oncol 8:638-647, 1990
25. Freedman AS, Takvorian T, Anderson KC, et al: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784-791, 1990